These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25476796)

  • 1. Preclinical biosafety evaluation of cell-based therapies: emerging global paradigms.
    Basu J; Assaf BT; Bertram TA; Rao M
    Toxicol Pathol; 2015 Jan; 43(1):115-25. PubMed ID: 25476796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue engineering and regenerative medicine: role of toxicologic pathologists for an emerging medical technology.
    Jayo MJ; Watson DD; Wagner BJ; Bertram TA
    Toxicol Pathol; 2008 Jan; 36(1):92-6. PubMed ID: 18337226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational Cell Therapies in Regenerative Medicine and Cancers.
    Lin SZ
    Cell Transplant; 2016; 25(5):781-2. PubMed ID: 27102174
    [No Abstract]   [Full Text] [Related]  

  • 4. Manufacturing challenges in regenerative medicine.
    Martin I; Simmons PJ; Williams DF
    Sci Transl Med; 2014 Apr; 6(232):232fs16. PubMed ID: 24739757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Translation of Regenerative Therapies.
    Allickson JG
    Clin Pharmacol Ther; 2017 Jan; 101(1):28-30. PubMed ID: 27806427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Regenerative Medicine Products.
    Gee AP
    Adv Exp Med Biol; 2018; 1098():189-198. PubMed ID: 30238372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GMP-compliant human adipose tissue-derived mesenchymal stem cells for cellular therapy.
    Aghayan HR; Goodarzi P; Arjmand B
    Methods Mol Biol; 2015; 1283():93-107. PubMed ID: 25138723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Science-based assessment of source materials for cell-based medicines: report of a stakeholders workshop.
    Stacey G; Andrews P; Asante C; Barbaric I; Barry J; Bisset L; Braybrook J; Buckle R; Chandra A; Coffey P; Crouch S; Driver P; Evans A; Gardner J; Ginty P; Goldring C; Hay DC; Healy L; Hows A; Hutchinson C; Jesson H; Kalber T; Kimber S; Leathers R; Moyle S; Murray T; Neale M; Pan D; Park BK; Rebolledo RE; Rees I; Rivolta MN; Ritchie A; Roos EJ; Saeb-Parsy K; Schröder B; Sebastian S; Thomas A; Thomas RJ; Turner M; Vallier L; Vitillo L; Webster A; Williams D
    Regen Med; 2018 Dec; 13(8):935-944. PubMed ID: 30488776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and myogenic differentiation of mesenchymal stem cells for urologic tissue engineering.
    Wu R; Liu G; Bharadwaj S; Zhang Y
    Methods Mol Biol; 2013; 1001():65-80. PubMed ID: 23494421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecules and small molecule drugs in regenerative medicine.
    Lu B; Atala A
    Drug Discov Today; 2014 Jun; 19(6):801-8. PubMed ID: 24252867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomaterials as carrier, barrier and reactor for cell-based regenerative medicine.
    Qi C; Yan X; Huang C; Melerzanov A; Du Y
    Protein Cell; 2015 Sep; 6(9):638-53. PubMed ID: 26088192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based therapies for the preterm infant.
    Zhu D; Wallace EM; Lim R
    Cytotherapy; 2014 Dec; 16(12):1614-28. PubMed ID: 25154811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue and stem/progenitor cells: discovery and development.
    Kapur SK; Dos-Anjos Vilaboa S; Llull R; Katz AJ
    Clin Plast Surg; 2015 Apr; 42(2):155-67. PubMed ID: 25827560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regenerative cell and tissue-based therapies for pulmonary arterial hypertension.
    Foster WS; Suen CM; Stewart DJ
    Can J Cardiol; 2014 Nov; 30(11):1350-60. PubMed ID: 25442435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications.
    Forostyak S; Jendelova P; Sykova E
    Biochimie; 2013 Dec; 95(12):2257-70. PubMed ID: 23994163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ Chips: Quality Assurance Systems in Regenerative Medicine.
    Pasqualini FS; Emmert MY; Parker KK; Hoerstrup SP
    Clin Pharmacol Ther; 2017 Jan; 101(1):31-34. PubMed ID: 27709615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mesenchymal stem cell-based therapy: Bench to Bedside].
    Kami D; Gojo S; Umezawa A
    Rinsho Ketsueki; 2013 May; 54(5):436-43. PubMed ID: 23727681
    [No Abstract]   [Full Text] [Related]  

  • 18. Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010.
    Mason C; Manzotti E
    Regen Med; 2010 May; 5(3):307-13. PubMed ID: 20455641
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotherapies in stroke.
    Detante O; Jaillard A; Moisan A; Barbieux M; Favre IM; Garambois K; Hommel M; Remy C
    Rev Neurol (Paris); 2014 Dec; 170(12):779-98. PubMed ID: 25459115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The translation of cell-based therapies: clinical landscape and manufacturing challenges.
    Heathman TR; Nienow AW; McCall MJ; Coopman K; Kara B; Hewitt CJ
    Regen Med; 2015; 10(1):49-64. PubMed ID: 25562352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.